Igkj-KO(BALB/c)
Nomenclature
BALB/cJSmo-Igkjem4Smoc
Cat. NO.
NM-KO-200581
Strain State
Embryo Cryopreservation
Model Description
Validation Data
Fig.1 FACS panel 1 designed for detecting T cells, B cells and NK cells in Igkj-KO (BALB/c)(21-week-old, male) and WT mice(21-week-old, male).
Fig.2 FACS panel 2 designed for detecting B cells in Igkj-KO (BALB/c)(21-week-old, male) and WT mice(21-week-old, male).
Fig.3 Spleen size and weight of WT BALB/c mice and Igkj-KO(BALB/c) mice. Compared with wild-type mice, spleen weight in HO Igkj-KO mice was reduced.
Abbr. HO, homozygous; WT, wild type.
Fig.4 Detection of the frequency of immune cell subsets in the blood and spleen by flow cytometry. In the peripheral blood and spleen, compared with WT mice, the proportion of B cells within CD45+ cells was reduced in HO Igkj-KO mice, with concomitant increases in T cell, NK cell and myeloid cell proportions.
Abbr. HO, homozygous; WT, wild type.
Fig.5 Detection of the frequency of B cell subsets in the blood and spleen by flow cytometry. Most B220+ cells were CD19+ cells in both WT and in HO Igkj-KO mice. In peripheral blood and spleen, Igkj-KO mice displayed reduced proportions of IgDhighIgMlow cells and elevated proportions of IgDlow/negativeIgMhigh and IgD-IgM- cells compared with WT mice.
Abbr. HO, homozygous; WT, wild type.
Fig.6 Detection of mouse IgG expression in serum of WT BALB/c mice and Igkj-KO(BALB/c) mice by ELISA. Igkj-KO mice displayed reduced serum mIgG level compared with WT mice. Serum were collected from wild-type BALB/c mice (n=2, 21 weeks old) and Igkj-KO(BALB/c) mice (n=2, 21 weeks old), and analyzed by ELISA.
Abbr. HO, homozygous; WT, wild type.
Fig.7 Detection of mIgG(kappa) and mIgG(lambda) expression in serum of WT BALB/c mice and Igkj-KO(BALB/c) mice by ELISA. Igkj-KO mice exhibited decreased mIgG(kappa) but elevated mIgG(lambda) in serum. Serum were collected from wild-type BALB/c mice (n=2, 21 weeks old) and Igkj-KO(BALB/c) mice (n=2, 21 weeks old), and analyzed by ELISA.
Abbr. HO, homozygous; WT, wild type
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
